Scientific Papers
NF Articles, Abstracts & Research Highlights
E-Medicine: Dermatologic Manifestations of Neurologic Disease
Theresa Conologue, DO, Staff Physician, Department of Dermatology, National Capital Consortium/Walter Reed Army Medical Center
Medical Journal Abstracts (Pub Med)
Enter search criteria (e.g. ‘NF1’ or ‘neurofibromatosis’) in the space provided. Click “Go.”
NF1 Specific
Clinical Manifestations and Management of Neurofibromatosis Type 1 
James H. Tonsgard,MD
Primary Care for Patients with Neurofibromatosis 1
Leigh Hart, RN, CCRN, PhD
Health Supervision for Children with Neurofibromatosis
Joseph H. Hersh and Committee on Genetics Journal of the American Academy of Pediatrics
Do hormonal contraceptives stimulate growth of neurofibromas?
A survey on 59 NF1 patients. Marge Lammert, Victor-Felix Mautner, and Lan Kluwe
Superficial Neurofibroma: A Lesion with Unique MRI Characteristics in Patients with Neurofibromatosis Type 1
Ruth Lim, Diego Jaramillo, Tina Young Poussaint, Yuchiao Chang and Bruce Korf.
NF: Brain tumor study reveals why treatment efforts fail in genetic disorder
From Washington University School of Medicine
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).
Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR.
Self-Concept of Children with NF1
Belinda Barton and Kathryn North
Neurofibromin Regulates Corticostriatal Inhibitory Networks during Working Memory Performance
Dept. of Neurobiology, University of California, Los Angeles
Molecular and Cellular Mechanisms of Learning Disabilities: A Focus on NF1
C. Shilyansky, Y.S. Lee and A.J. Silva
Phase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas
R.I. Jakacki, E. Dombi, D.M. Potter, S. Goldman, J.C. Allen, I.F. Pollack, and B.C. Widemann
Practical Genetics: Neurofibromatosis 1
Rosalie E Ferner, Department of Neurology, Guy’s and St Thomas’ Hospitals, London, UK
NF2 Specific
Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation
Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW
Correlation between VEGF expression and MVD in sporadic and NF2-related schwannomas
Ditomaso E, Stemmer-Rachamimov A, Potts A, Drottar M, Jain RK, Plotkin SR
The Neurofibromatosis 2 Protein, Merlin, Regulates Glial Cell Growth in an ErbB2- and Src-Dependent Manner
Houshmandi SS, Emnett RJ, Giovannini M, Gutmann DH
Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib
Plotkin SR, Halpin CF, McKenna MJ, Batchelor TT, Loeffler JS, Barker FG
Merlin Is a Potent Inhibitor of Glioma Growth
Lau YKI, Murray LB, Houshmandi SS, Xu Y, Gutmann DH, Yu Q
CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice
Demestre M, Messerli SM, Celli N, ShahhossinimM, Kluwe L, Mautner V, Maruta H
Neurofibromatosis Type 2 (NF2): A clinical and molecular view
D. Gareth R. Evans
Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients
Scott R. Plotkin, M.D., Ph.D., Caroline C. O’Donnell, B.A., R.N., William T. Curry Jr., M.D., Catherine M. Bove, M.Ed., A.P.N.G., Mia MacCollin, M.D., and Fabio P. Nunes, M.D.
Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function
Chunzhang Yang, Ashok R. Asthagiri, Rajiv R. Iyer, Jie Lu, David S. Xu, Alexander Ksendzovsky, Roscoe O. Brady, Zhengping Zhuang, and Russell R. Lonser
Following A Path To A Potential Therapy For NF2, A Rare Tumor Disorder
Source: Greg Lester, The Wistar Institute
